Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (4-(3-fluoro-5-trifluoromethylpyridin-2-yl)piperazin-1-yl)(5-methanesulfonyl-2-(2,2,2-trifluoro-1-methylethoxy)phenyl)methanone
2. Rg 1678
3. Rg-1678
4. Rg1678
1. 845614-11-1
2. Paliflutine
3. Rg1678
4. Ro-4917838
5. Ro4917838
6. Rg-1678
7. R-1678
8. Q8l6an59yy
9. Chembl1171829
10. (s)-(4-(3-fluoro-5-(trifluoromethyl)pyridin-2-yl)piperazin-1-yl)(5-(methylsulfonyl)-2-((1,1,1-trifluoropropan-2-yl)oxy)phenyl)methanone
11. Ro-4917939
12. (4-(3-fluoro-5-trifluoromethylpyridin-2-yl)piperazin-1-yl)(5-methylsulfonyl-2-(((s)-2,2,2-trifluoro-1-methylethyl)oxy)phenyl)methanone
13. (s)-(4-(3-fluoro-5-trifluoromethylpyridin-2-yl)piperazin-1-yl)(5-(methanesulfonyl)-2-(2,2,2-trifluoro-1-methylethoxy)phenyl)methanone
14. [4-[3-fluoro-5-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl]-[5-methylsulfonyl-2-[(2s)-1,1,1-trifluoropropan-2-yl]oxyphenyl]methanone
15. [4-(3-fluoro-5-trifluoromethylpyridin-2-yl)piperazin-1-yl][5-methylsulfonyl-2-[((s)-2,2,2-trifluoro-1-methylethyl)oxy]phenyl]methanone
16. Piperazine, 1-(3-fluoro-5-(trifluoromethyl)-2-pyridinyl)-4-(5-(methylsulfonyl)-2-((1s)-2,2,2-trifluoro-1-methylethoxy)benzoyl)-
17. Paliflutine [inn]
18. Bitopertin [usan:inn]
19. Unii-q8l6an59yy
20. Rg 1678
21. Methanone, (4-(3-fluoro-5-(trifluoromethyl)-2-pyridinyl)-1-piperazinyl)(5-(methylsulfonyl)-2-((1s)-2,2,2-trifluoro-1-methylethoxy)phenyl)-
22. Methanone, [4-[3-fluoro-5-(trifluoromethyl)-2-pyridinyl]-1-piperazinyl][5-(methylsulfonyl)-2-[(1s)-2,2,2-trifluoro-1-methylethoxy]phenyl]-
23. Ro 4917939
24. Bitopertin [inn]
25. Bitopertin [jan]
26. Bitopertin (jan/usan)
27. Bitopertin [usan]
28. Ro 4917838
29. R 1678
30. Bitopertin [who-dd]
31. Schembl562490
32. Gtpl7546
33. Dtxsid80233556
34. Hms3886d08
35. Bdbm50322423
36. Mfcd18251496
37. S8219
38. Zinc53294258
39. Akos022185256
40. Bcp9001046
41. Ccg-269972
42. Cs-0939
43. Db12426
44. Ncgc00379029-01
45. Ac-33092
46. As-75194
47. Bitopertin (rg1678,ro-4917838)
48. Hy-10809
49. Methanone, (4-(3-fluoro-5-(trifluoromethyl)-2-pyridinyl)-1-piperazinyl)(5-(methylsulfonyl)-2-((1s)-2,2,2-trifluoro-1-methylethoxy)phenyl)-palmitoyl Oligopeptide
50. Methanone, [4-[3-fluoro-5-(trifluoromethyl)-2-pyridinyl]-1-piperazinyl][5-(methylsulfonyl)-2-[(1s)-2
51. A15021
52. D10186
53. Q4918919
54. (4-(3-fluoro-5-(trifluoromethyl)pyridin-2-yl)piperazin-1-yl)(5-(methanesulfonyl)-2-(((2s)-1,1,1-trifluoropropan-2-yl)oxy)phenyl)methanone
55. (4-(3-fluoro-5-trifluoromethylpyridin-2-yl)piperazin-1-yl)(5-methanesulfonyl-2-(2,2,2-trifluoro-1-methylethoxy)phenyl)methanone
56. (s)-4-(3-fluoro-5-trifluoromethylpyridin-2-yl)piperazin-1-yl]-[5-methanesulfonyl-2-(2,2,2-trifluoro-1-methylethoxy)phenyl]-methanone
57. 1-[3-fluoro-5-(trifluoromethyl)pyridin-2-yl]-4-(5-methanesulfonyl-2-{[(2s)-1,1,1-trifluoropropan-2-yl]oxy}benzoyl)piperazine
| Molecular Weight | 543.5 g/mol |
|---|---|
| Molecular Formula | C21H20F7N3O4S |
| XLogP3 | 4 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 13 |
| Rotatable Bond Count | 5 |
| Exact Mass | 543.10627444 g/mol |
| Monoisotopic Mass | 543.10627444 g/mol |
| Topological Polar Surface Area | 88.2 Ų |
| Heavy Atom Count | 36 |
| Formal Charge | 0 |
| Complexity | 872 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Treatment of schizophrenia
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Bitopertin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bitopertin, including repackagers and relabelers. The FDA regulates Bitopertin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bitopertin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Bitopertin supplier is an individual or a company that provides Bitopertin active pharmaceutical ingredient (API) or Bitopertin finished formulations upon request. The Bitopertin suppliers may include Bitopertin API manufacturers, exporters, distributors and traders.
Bitopertin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Bitopertin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Bitopertin GMP manufacturer or Bitopertin GMP API supplier for your needs.
A Bitopertin CoA (Certificate of Analysis) is a formal document that attests to Bitopertin's compliance with Bitopertin specifications and serves as a tool for batch-level quality control.
Bitopertin CoA mostly includes findings from lab analyses of a specific batch. For each Bitopertin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Bitopertin may be tested according to a variety of international standards, such as European Pharmacopoeia (Bitopertin EP), Bitopertin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Bitopertin USP).
LOOKING FOR A SUPPLIER?
